ATE81777T1 - Gefriergetrocknete pulverfoermige cyclophosphamidzusammensetzung sowie verfahren zu deren herstellung. - Google Patents

Gefriergetrocknete pulverfoermige cyclophosphamidzusammensetzung sowie verfahren zu deren herstellung.

Info

Publication number
ATE81777T1
ATE81777T1 AT90201352T AT90201352T ATE81777T1 AT E81777 T1 ATE81777 T1 AT E81777T1 AT 90201352 T AT90201352 T AT 90201352T AT 90201352 T AT90201352 T AT 90201352T AT E81777 T1 ATE81777 T1 AT E81777T1
Authority
AT
Austria
Prior art keywords
freeze
cyclophosphamide
dried powder
powder composition
same manufacture
Prior art date
Application number
AT90201352T
Other languages
English (en)
Inventor
Alfred James Nijkerk
Johanna Maria Pieterne Vermeer
Original Assignee
Pharmachemie Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmachemie Bv filed Critical Pharmachemie Bv
Application granted granted Critical
Publication of ATE81777T1 publication Critical patent/ATE81777T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/675Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AT90201352T 1989-06-06 1990-05-28 Gefriergetrocknete pulverfoermige cyclophosphamidzusammensetzung sowie verfahren zu deren herstellung. ATE81777T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL8901431A NL8901431A (nl) 1989-06-06 1989-06-06 Gevriesdroogd, poedervormig cyclofosfamidepreparaat, alsmede werkwijze ter bereiding daarvan.
EP90201352A EP0401894B1 (de) 1989-06-06 1990-05-28 Gefriergetrocknete pulverförmige Cyclophosphamidzusammensetzung sowie Verfahren zu deren Herstellung

Publications (1)

Publication Number Publication Date
ATE81777T1 true ATE81777T1 (de) 1992-11-15

Family

ID=19854783

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90201352T ATE81777T1 (de) 1989-06-06 1990-05-28 Gefriergetrocknete pulverfoermige cyclophosphamidzusammensetzung sowie verfahren zu deren herstellung.

Country Status (4)

Country Link
EP (1) EP0401894B1 (de)
AT (1) ATE81777T1 (de)
DE (1) DE69000412D1 (de)
NL (1) NL8901431A (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2001552C (en) * 1988-11-14 1997-07-22 The Upjohn Company Cyclophosphamide - sodium bicarbonate lyophilizates
US5418223A (en) * 1993-05-20 1995-05-23 Erbamont, Inc. Method for lyophilization of cyclophosphamide and product
US6613927B1 (en) * 2002-02-08 2003-09-02 American Pharmaceutical Partners, Inc. Sterile lyophilized ifosfamide and associated methods

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4537883A (en) * 1982-11-12 1985-08-27 Mead Johnson & Company Lyophilized cyclophosphamide
US4659699A (en) * 1983-08-22 1987-04-21 Cetus-Ben Venue Therapeutics Process for freeze drying cyclophosphamide

Also Published As

Publication number Publication date
EP0401894A1 (de) 1990-12-12
NL8901431A (nl) 1991-01-02
DE69000412D1 (de) 1992-12-03
EP0401894B1 (de) 1992-10-28

Similar Documents

Publication Publication Date Title
DK0707580T3 (da) Magnesiumomeprazol
HU9401445D0 (en) Nor-bile-acid derivatives, process for producing them and pharmaceutical compositions containing them
HU913010D0 (en) Method for producing inhibitors of calcium ingestion
ES2072163T3 (es) Compuestos de inclusion de acido 5,10-metilenotetrahidrofolico y ciclodextrina.
DE59008170D1 (de) Verfahren zur Herstellung mikronisierter bioabbaubarer Partikel.
FI901328A0 (fi) Menetelmä farmaseuttisesti käyttökelpoisen (7 ,17 )-17-hydroksi-7-metyyli-19-nor-17-pregn-5(10)-en-20-yn-3-onin valmistamiseksi kiteisenä puhtaana muotona
DE69427955D1 (de) Verfahren zur Herstellung von 2,2-Difluorketensilylacetalen und alpha,alpha-Difluor-beta -Silyloxy-1,3-Dioxolan-4-Propansäureestern
ATE81777T1 (de) Gefriergetrocknete pulverfoermige cyclophosphamidzusammensetzung sowie verfahren zu deren herstellung.
DE69210069T2 (de) Verfahren zur Herstellung von 1,3-Dioxolen
HU913011D0 (en) Method for producing inhibitors of calcium ingestion
HU9202103D0 (en) Method for producing inosite-phosphate analogues and pharmaceutical preparatives containing these compounds
PH20151A (en) Alpha-arginine isoxicamate
IL72726A0 (en) Crystalline salts of l or(s)-3-(3,4-dihydroxyphenyl)-2-methylalanine esters,their preparation and pharmaceutical compositions containing them
RU92016566A (ru) Биокерамическая система для ввода биологически активных соединений, способ ее получения, фармацевтическое средство, способ применения биокерамической системы